Paul Langerhans Institut Dresden

The program of the Paul Langerhans Institute Dresden (PLID) includes research into the pathophysiology of type 1 and type 2 diabetes mellitus. The main focus is on the mechanisms which cause the destruction and/or limited function of pancreatic beta cells and insufficient insulin secretion.
In addition, PLID also plays an outstanding role as only German transplant center for human pancreatic islet cells.

Associated groups

  • Prof. Dr. Dr. Michele Solimena
  • Prof. Dr. Andreas Birkenfeld
  • Prof. Dr. Ezio Bonifacio
  • Prof. Dr. Stefan Bornstein
  • Prof. Dr. Triantafyllos Chavakis
  • Prof. Dr. Karsten Kretschmer
  • Prof. Dr. Peter Schwarz
  • Prof. Dr. Stephan Speier
  • Prof. Dr. Jürgen Weitz
  • Dr. Ünal Coskun
  • Dr. Anthony Gavalas
  • Dr. Barbara Ludwig
  • Dr. Nikolay Ninov
  • Dr. Thilo Welsch

 

Contribution to the DZD research program

  • Transplantation of human pancreatic islets
  • Molecular mechanisms and systems biology of insulin granules
  • Identification of new therapy goals for increasing beta cell mass and insulin secretion
  • Functional beta cell imaging
  • Prevention and immune tolerance for type 1 diabetes
  • Prevention, genotyping and phenotypic characterization of type 2 diabetes
  • Participation in the clinical studies of the DZD

Speaker

Michele Solimena, MD, PhD

Professor of Molecular Diabetology
Executive Director of the Paul Langerhans Institute Dresden

Contact

Paul Langerhans Institute Dresden of the Helmholtz Zentrum München University Hospital and Faculty of Medicine Carl Gustav Carus of TU Dresden
Fetscherstrasse 74
01307 Dresden
Germany

+49 (0)351 7963 6611

michele.solimena(at)tu-dresden.de